Cost-analysis of infliximab and etanercept in the treatment of rheumatoid artritis patients in Spain, based on a Pharmacoeconomic model, and budgetary impact analysis of the results
Annual Scientific Meeting of American College of Rheumatology (ACR). San Antonio, Texas. 16-21 oct 2004
Maymó J, Pérez C, Poveda JL, Casado MA, Fosbrook L, Merino P